Abstract
dc:description.abstractMeningococcal disease is a globally important cause of mortality and morbidity,<br/>particularly in the meningitis belt of Sub-Saharan Africa. The causative agent, Neisseria<br/>meningitidis, commonly colonises the human nasopharynx asymptomatically, but<br/>occasionally becomes invasive, resulting in fulminant disease.<br/><br/>Neisseria lactamica is a closely related bacterium which colonises the same niche,<br/>but is non-pathogenic. Colonisation with N. lactamica may provide protection from<br/>colonisation with N. meningitidis, and from meningococcal disease. A controlled human<br/>infection model has previously been developed, using nasal inoculation to induce<br/>nasopharyngeal colonisation with N. lactamica, with a subsequent reduction in N.<br/>meningitidis carriage demonstrated.<br/><br/>This thesis describes four controlled human infection studies designed to optimise<br/>and further develop this model. In the first study, the impact of duration of colonisation on<br/>immunogenicity was assessed by allowing participants to remain colonised for a short, or<br/>longer period after inoculation. The use of an increased inoculum dose, antibiotic<br/>clearance of colonisation, and the shedding of bacteria were also investigated.<br/><br/>The second study involved challenge with a genetically modified strain of N.<br/>lactamica expressing the meningococcal antigen NadA. This study aimed to investigate<br/>the immunological impact of the expression of a bespoke, heterologous antigen during<br/>asymptomatic colonisation.<br/><br/>The final two studies investigated the use of a lyophilised preparation of N.<br/>lactamica, aiming to make the model feasible for use in a lower resourced setting, beyond<br/>a reliable cold-chain. Dose-ranging studies were conducted in the UK, and subsequently<br/>in Mali, within the meningitis belt. The impact of lyophilisation on the ability of N. lactamica<br/>to colonise the nasopharynx, and to induce an immune response, was investigated.<br/><br/>These studies have confirmed that intranasal inoculation with both wild-type and<br/>genetically modified strains of N. lactamica safely induces long-standing nasopharyngeal<br/>colonisation in a high proportion of individuals. This colonisation induces N. lactamica<br/>specific and cross-reactive N. meningitidis specific immune responses. An immune<br/>response specific to a heterologous antigen can be induced by expression of that antigen<br/>by recombinant N. lactamica. Lyophilisation of N. lactamica is safe, feasible, and does not<br/>reduce colonisation potential or immunogenicity. Use of the model within the meningitis<br/>belt is feasible, safe and induces a similar pattern of colonisation and immunogenicity.<br/><br/>Future studies will investigate the impact of N. lactamica colonisation on<br/>meningococcal carriage and disease in the meningitis belt, and the use of further genetic<br/>manipulation to improve cross-reactive immunity to N. meningitidis, with the overall aim of<br/>developing improved strategies for protection from meningococcal disease.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Gbesemete, Diane Frances
- Advisors dc:contributor.advisor
-
- Read, Robert
- Faust, Saul
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng